TipRanks
Advertisement
Advertisement

DE:8EV Stock Latest News

TheraCryf Sets Results Date as Lead Addiction Therapy Nears Clinical Readiness
Company AnnouncementsTheraCryf Sets Results Date as Lead Addiction Therapy Nears Clinical Readiness
9d ago
TheraCryf Wins Shareholder Backing for £1.05m Fundraise and Share Subdivision
PremiumCompany Announcements
TheraCryf Wins Shareholder Backing for £1.05m Fundraise and Share Subdivision
16d ago
TheraCryf raises £1.05m to advance addiction drug towards Phase 1 trials
PremiumCompany Announcements
TheraCryf raises £1.05m to advance addiction drug towards Phase 1 trials
1M ago
TheraCryf Reports Strong Toxicology Data and Manufacturing Progress for Lead Addiction Drug
PremiumCompany Announcements
TheraCryf Reports Strong Toxicology Data and Manufacturing Progress for Lead Addiction Drug
4M ago
TheraCryf to Host Investor Webinar as Lead Addiction Drug Nears Clinical Stage
PremiumCompany Announcements
TheraCryf to Host Investor Webinar as Lead Addiction Drug Nears Clinical Stage
5M ago
TheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
PremiumCompany AnnouncementsTheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
5M ago
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
Premium
Company Announcements
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
5M ago
TheraCryf Rejects Bid for Lead Neuropsychiatry Assets, Backs In-House Growth Strategy
Premium
Company Announcements
TheraCryf Rejects Bid for Lead Neuropsychiatry Assets, Backs In-House Growth Strategy
5M ago
TheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone
PremiumCompany Announcements
TheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone
6M ago
TheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage
PremiumCompany Announcements
TheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage
8M ago
TheraCryf Hits Key Manufacturing Milestone for Ox-1 Addiction Candidate
PremiumCompany Announcements
TheraCryf Hits Key Manufacturing Milestone for Ox-1 Addiction Candidate
9M ago
TheraCryf Announces Progress on Preclinical Fatigue Treatment Program
PremiumCompany Announcements
TheraCryf Announces Progress on Preclinical Fatigue Treatment Program
9M ago
TheraCryf Advances Addiction Treatment Program with Strategic Developments
PremiumCompany AnnouncementsTheraCryf Advances Addiction Treatment Program with Strategic Developments
10M ago
TheraCryf Advances Ox-1 Program Amidst Addiction Awareness Week
Premium
Company Announcements
TheraCryf Advances Ox-1 Program Amidst Addiction Awareness Week
10M ago
TheraCryf Advances Addiction Treatment Program Amidst Awareness Week
Premium
Company Announcements
TheraCryf Advances Addiction Treatment Program Amidst Awareness Week
10M ago
TheraCryf plc to Announce Half-Year Results on 3 December 2025
PremiumCompany Announcements
TheraCryf plc to Announce Half-Year Results on 3 December 2025
10M ago
TheraCryf Achieves Key Milestone in Ox-1 Addiction Program
PremiumCompany Announcements
TheraCryf Achieves Key Milestone in Ox-1 Addiction Program
11M ago
TheraCryf Director Increases Stake, Signaling Confidence in Strategic Direction
PremiumCompany Announcements
TheraCryf Director Increases Stake, Signaling Confidence in Strategic Direction
11M ago
TheraCryf Highlights Mental Health Initiatives and Q4 Conference Plans
PremiumCompany Announcements
TheraCryf Highlights Mental Health Initiatives and Q4 Conference Plans
12M ago
TheraCryf Secures Korean Patent and Advances Ox-1 Development
PremiumCompany AnnouncementsTheraCryf Secures Korean Patent and Advances Ox-1 Development
1y ago
TheraCryf Advances Ox-1 Development with Manufacturing Scale-Up
Premium
Company Announcements
TheraCryf Advances Ox-1 Development with Manufacturing Scale-Up
1y ago
TheraCryf plc Successfully Passes All Resolutions at AGM
Premium
Company Announcements
TheraCryf plc Successfully Passes All Resolutions at AGM
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >